EWU vs IBB
iShares MSCI United Kingdom ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.50% for EWU.
- • EWU pays a higher dividend yield (3.14%).
Side-by-side metrics
| Metric | EWU | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.50% | 0.44% |
Dividend yield Trailing 12-month yield. | 3.14% | 0.16% |
AUM Assets under management — bigger funds are typically more liquid. | $3.73B | $11.50B |
YTD return | 11.45% | 30.22% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.66 | 0.60 |
P/E ratio | 16.65 | 25.48 |
Last price | $47.78 | $217.75 |
Inception | — | — |
Issuer | iShares | iShares |
EWU top holdings
| SHEL.L | Shell PLC | 9.88% |
| HSBA.L | HSBC Holdings PLC | 9.30% |
| AZN.L | AstraZeneca PLC | 8.93% |
| ULVR.L | Unilever PLC | 4.44% |
| RR.L | Rolls-Royce Holdings PLC | 4.37% |
| BP.L | BP PLC | 4.17% |
| BATS.L | British American Tobacco PLC | 3.89% |
| GSK.L | GSK PLC | 3.17% |
| RIO.L | Rio Tinto PLC Ordinary Shares | 2.75% |
| NG.L | National Grid PLC | 2.64% |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
About EWU
EWU (iShares MSCI United Kingdom ETF) is UK large and mid-cap equities. Managed by iShares, the fund carries $3.7B in assets under management, an expense ratio of 0.50%, a dividend yield of 3.14%. Its largest holding is Shell PLC (SHEL.L), which represents 9.9% of the portfolio. Real Estate is the fund's largest sector exposure at 0.7%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.